Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asthma, Allergic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00666341
What this trial is testing

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Who this might be right for
Type I-Allergy
Allergopharma GmbH & Co. KG 50
Not applicableStudy completedNCT00736801
What this trial is testing

Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma

Who this might be right for
Allergic Asthma
University of Rostock 35
Not applicableStudy completedNCT02813811
What this trial is testing

Laminar Airflow in Severe Asthma for Exacerbation Reduction - 48 Month Follow-up.

Who this might be right for
Asthma
Portsmouth Hospitals NHS Trust 77
Large-scale testing (Phase 3)Study completedNCT04145219
What this trial is testing

House Dust Mite Allergy Trial In Children

Who this might be right for
Allergic Rhinitis Due to Dermatophagoides FarinaeAllergic Rhinitis Due to Dermatophagoides PteronyssinusAllergic Rhinitis Due to House Dust Mite
ALK-Abelló A/S 1,460
Not applicableUnknownNCT06021912
What this trial is testing

E-ITAG Allergen Immunotherapy in the Management of Allergic Asthma

Who this might be right for
Study the Efficacy of ITA in Patients With Allergic Asthma or Allergic Rhinitis or Allergic Rhinitis Compared With Conventional Treatment
General Administration of Military Health, Tunisia 300
Large-scale testing (Phase 3)UnknownNCT05400811
What this trial is testing

Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Who this might be right for
House Dust Mite AllergyPerennial Allergic RhinitisAllergic Rhinoconjunctivitis+1 more
Inmunotek S.L. 400
Not applicableWithdrawnNCT01144910
What this trial is testing

The Long-term Prognosis of Moderate to Severe Bronchial Hyperresponsiveness (BHR) in Asthmatic Preschool Children

Who this might be right for
Intrinsic AsthmaAllergic AsthmaAllergy+1 more
Johann Wolfgang Goethe University Hospital
Testing effectiveness (Phase 2)Study completedNCT02446613
What this trial is testing

Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958

Who this might be right for
Asthma and Rhinitis
GlaxoSmithKline 16
Testing effectiveness (Phase 2)Study completedNCT02532179
What this trial is testing

Subcutaneous Immunotherapy for Mouse in Adults

Who this might be right for
AsthmaPerennial Allergic Rhinitis
National Institute of Allergy and Infectious Diseases (NIAID) 12
Large-scale testing (Phase 3)Study completedNCT01392859
What this trial is testing

Characterization of the Role of Histamine in Children With Asthma

Who this might be right for
AsthmaAllergic AsthmaNon-allergic Asthma
Children's Mercy Hospital Kansas City 211
Not applicableStudy completedNCT05157087
What this trial is testing

XOLAIR (Omalizumab) Outcomes in Pediatric Allergic Asthma Patients in the United States

Who this might be right for
Asthma
Novartis Pharmaceuticals 16,246
Large-scale testing (Phase 3)Study completedNCT00389363
What this trial is testing

Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects

Who this might be right for
Asthma
ALK-Abelló A/S 800
Post-approval studies (Phase 4)Study completedNCT00250263
What this trial is testing

A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy

Who this might be right for
Allergic RhinitisAsthma
Bayside Health 30
Large-scale testing (Phase 3)Study completedNCT00633919
What this trial is testing

Efficacy of SLITone in House Dust Mite Allergic Patients

Who this might be right for
Allergy
ALK-Abelló A/S 124
Not applicableStudy completedNCT03665701
What this trial is testing

Characterization of the Inhibitory Effects of Fevipiprant (QAW039) on Activation of Eosinophils and ILC2 Cells by Prostaglandin D2 Metabolites

Who this might be right for
Atopic Asthma
Fraunhofer-Institute of Toxicology and Experimental Medicine 17
Not applicableUnknownNCT01795846
What this trial is testing

Evaluation of Immunological Changes and Clinical Efficacy of Specific Immunotherapy With Der p House Dust Mite Allergen in Polysensitized and Monosensitized Patients With Allergic Rhinitis and/or Asthma.

Who this might be right for
Allergen Immunotherapy, Immunological Mechanisms,Monosensitized,Polysensitized,Clinical Efficacy
Ankara University 40
Not applicableStudy completedNCT01420003
What this trial is testing

Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics

Who this might be right for
Atopic Asthma
Hamilton Health Sciences Corporation 12
Testing effectiveness (Phase 2)Study completedNCT00941577
What this trial is testing

Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

Who this might be right for
Asthma
Altair Therapeutics, Inc. 30
Not applicableLooking for participantsNCT05938972
What this trial is testing

Real Life Study of Biologicals in Patients With Severe CRSwNP

Who this might be right for
Chronic Rhinosinusitis With Nasal Polyps
University Hospital, Ghent 180
Post-approval studies (Phase 4)Study completedNCT01125748
What this trial is testing

A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy

Who this might be right for
Allergic Asthma
Genentech, Inc. 176
Next Page